88 related articles for article (PubMed ID: 17196075)
1. In vitro comparison of two delivery devices for administering formoterol: Foradil P and formoterol ratiopharm single-dose capsule inhaler.
Criée CP; Meyer T; Petro W; Sommerer K; Zeising P
J Aerosol Med; 2006; 19(4):466-72. PubMed ID: 17196075
[TBL] [Abstract][Full Text] [Related]
2. In vitro testing of two formoterol dry powder inhalers at different flow rates.
Weuthen T; Roeder S; Brand P; Müllinger B; Scheuch G
J Aerosol Med; 2002; 15(3):297-303. PubMed ID: 12396417
[TBL] [Abstract][Full Text] [Related]
3. In vitro aerosol performance and dose uniformity between the Foradile Aerolizer and the Oxis Turbuhaler.
Chew NY; Chan HK
J Aerosol Med; 2001; 14(4):495-501. PubMed ID: 11791690
[TBL] [Abstract][Full Text] [Related]
4. Formoterol delivered via a new multi-dose dry powder inhaler (Certihaler) is as effective and well tolerated as the formoterol dry powder inhaler (Aerolizer) in children with persistent asthma.
Chuchalin AG; Manjra AI; Rozinova NN; Skopková O; Cioppa GD; Till D; Kaiser G; Fashola T; Kottakis J
J Aerosol Med; 2005; 18(1):63-73. PubMed ID: 15741775
[TBL] [Abstract][Full Text] [Related]
5. Comparable efficacy and tolerability of formoterol (Foradil) administered via a novel multi-dose dry powder inhaler (Certihaler) or the Aerolizer dry powder inhaler in patients with persistent asthma.
Dahl R; Creemers JP; Van Noord J; Sips A; Della Cioppa G; Thomson M; Andriano K; Kottakis J; Fashola T
Respiration; 2004; 71(2):126-33. PubMed ID: 15031566
[TBL] [Abstract][Full Text] [Related]
6. Inhalation devices for long-acting beta2-agonists: efficiency and ease of use of dry powder formoterol inhalers for use by patients with asthma and COPD.
Molimard M; Till D; Stenglein S; Singh D; Krummen M
Curr Med Res Opin; 2007 Oct; 23(10):2405-13. PubMed ID: 20350055
[TBL] [Abstract][Full Text] [Related]
7. In vitro drug delivery performance of a new budesonide/formoterol pressurized metered-dose inhaler.
Chambers F; Ludzik A
J Aerosol Med Pulm Drug Deliv; 2009 Jun; 22(2):113-20. PubMed ID: 19422311
[TBL] [Abstract][Full Text] [Related]
8. Pharmacokinetics and tolerability of formoterol in healthy volunteers after a single high dose of Foradil dry powder inhalation via Aerolizer.
Lecaillon JB; Kaiser G; Palmisano M; Morgan J; Della Cioppa G
Eur J Clin Pharmacol; 1999 Apr; 55(2):131-8. PubMed ID: 10335908
[TBL] [Abstract][Full Text] [Related]
9. Clinically equivalent bronchodilatation achieved with formoterol delivered via Easyhaler and Aerolizer.
Dubakiene R; Nargela R; Sakalauskas R; Vahteristo M; Silvasti M; Lähelmä S
Respiration; 2006; 73(4):441-8. PubMed ID: 16432294
[TBL] [Abstract][Full Text] [Related]
10. Similar efficacy following four weeks treatment of asthmatics with formoterol 12 micrograms b.d. delivered by two different dry powder inhalers: differences in inhaler handling.
Eliraz A; Ramirez-Rivera A; Ferranti P; Holzer R; García JM; Turcotte C; Rapatz G; Pfister P; Overend T; Kottakis J
Int J Clin Pract; 2001 Apr; 55(3):164-70. PubMed ID: 11351769
[TBL] [Abstract][Full Text] [Related]
11. Delivery of formoterol from a novel multi-dose inhaler Airmax.
Zeng XM; Jones S; O'Leary D; Phelan M; Colledge J
Respir Med; 2002 Jun; 96(6):397-403. PubMed ID: 12117038
[TBL] [Abstract][Full Text] [Related]
12. Deposition of Foradil P in human lungs: comparison of in vitro and in vivo data.
Meyer T; Brand P; Ehlich H; Köbrich R; Meyer G; Riedinger F; Sommerer K; Weuthen T; Scheuch G
J Aerosol Med; 2004; 17(1):43-9. PubMed ID: 15120012
[TBL] [Abstract][Full Text] [Related]
13. Efficacy and safety of budesonide/formoterol single inhaler therapy versus a higher dose of budesonide in moderate to severe asthma.
Scicchitano R; Aalbers R; Ukena D; Manjra A; Fouquert L; Centanni S; Boulet LP; Naya IP; Hultquist C
Curr Med Res Opin; 2004 Sep; 20(9):1403-18. PubMed ID: 15383189
[TBL] [Abstract][Full Text] [Related]
14. In-vitro intra- and inter-inhaler flow rate-dependent dosage emission from a combination of budesonide and eformoterol in a dry powder inhaler.
Tarsin W; Assi KH; Chrystyn H
J Aerosol Med; 2004; 17(1):25-32. PubMed ID: 15120010
[TBL] [Abstract][Full Text] [Related]
15. Inspiratory flow rates and volumes with the Aerolizer dry powder inhaler in asthmatic children and adults.
Bronsky EA; Grossman J; Henis MJ; Gallo PP; Yegen U; Della Cioppa G; Kottakis J; Mehra S
Curr Med Res Opin; 2004; 20(2):131-7. PubMed ID: 15006006
[TBL] [Abstract][Full Text] [Related]
16. Single-dose pharmacokinetics and safety pharmacodynamics of formoterol delivered by two different dry powder inhalers.
Petzold U; Kremer HJ; Nguyen DT; Munzel U; Dietrich H; Maus J
J Aerosol Med Pulm Drug Deliv; 2008 Sep; 21(3):309-19. PubMed ID: 18598160
[TBL] [Abstract][Full Text] [Related]
17. Efficacy of Formoterol Fumarate Delivered by Metered Dose Inhaler Using Co-Suspension™ Delivery Technology Versus Foradil® Aerolizer® in Moderate-To-Severe COPD: A Randomized, Dose-Ranging Study.
Sethi S; Fogarty C; Hanania NA; Martinez FJ; Rennard S; Fries M; Orevillo C; Darken P; St Rose E; Strom S; Fischer T; Golden M; Dwivedi S; Reisner C
Chronic Obstr Pulm Dis; 2016 Nov; 4(1):21-33. PubMed ID: 28848908
[No Abstract] [Full Text] [Related]
18. A randomized study of formoterol fumarate in a porous particle metered-dose inhaler in patients with moderate-to-severe COPD.
Quinn D; Seale JP; Reisner C; Fischer T; Golden M; Fernandez C; Darken P; St Rose E; Thomas M; Tardie G; Orevillo C
Respir Med; 2014 Sep; 108(9):1327-35. PubMed ID: 25060541
[TBL] [Abstract][Full Text] [Related]
19. Efficacy and safety of formoterol delivered via a new multidose dry powder inhaler (Certihaler) in adolescents and adults with persistent asthma.
LaForce C; Prenner BM; Andriano K; Lavecchia C; Yegen U
J Asthma; 2005 Mar; 42(2):101-6. PubMed ID: 15871441
[TBL] [Abstract][Full Text] [Related]
20. The role of capsule aperture size on the dispersion of carrier-based formulation at different air flowrates.
Tang P; Kakhi M; Albariqi A; Ravindra Babu Behara S; Walenga R; Yang R; Chan HK
Int J Pharm; 2023 Jul; 642():123152. PubMed ID: 37339687
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]